We've found
31,654
archived clinical trials in
Cardiology
We've found
31,654
archived clinical trials in
Cardiology
Trial to Assess Chelation Therapy (TACT)
Updated: 8/30/2013
Trial to Assess Chelation Therapy (TACT)
Status: Enrolling
Updated: 8/30/2013
Trial to Assess Chelation Therapy (TACT)
Updated: 8/30/2013
Trial to Assess Chelation Therapy (TACT)
Status: Enrolling
Updated: 8/30/2013
Click here to add this to my saved trials
Trial to Assess Chelation Therapy (TACT)
Updated: 8/30/2013
Trial to Assess Chelation Therapy (TACT)
Status: Enrolling
Updated: 8/30/2013
Trial to Assess Chelation Therapy (TACT)
Updated: 8/30/2013
Trial to Assess Chelation Therapy (TACT)
Status: Enrolling
Updated: 8/30/2013
Click here to add this to my saved trials
Trial to Assess Chelation Therapy (TACT)
Updated: 8/30/2013
Trial to Assess Chelation Therapy (TACT)
Status: Enrolling
Updated: 8/30/2013
Trial to Assess Chelation Therapy (TACT)
Updated: 8/30/2013
Trial to Assess Chelation Therapy (TACT)
Status: Enrolling
Updated: 8/30/2013
Click here to add this to my saved trials
Trial to Assess Chelation Therapy (TACT)
Updated: 8/30/2013
Trial to Assess Chelation Therapy (TACT)
Status: Enrolling
Updated: 8/30/2013
Trial to Assess Chelation Therapy (TACT)
Updated: 8/30/2013
Trial to Assess Chelation Therapy (TACT)
Status: Enrolling
Updated: 8/30/2013
Click here to add this to my saved trials
Trial to Assess Chelation Therapy (TACT)
Updated: 8/30/2013
Trial to Assess Chelation Therapy (TACT)
Status: Enrolling
Updated: 8/30/2013
Trial to Assess Chelation Therapy (TACT)
Updated: 8/30/2013
Trial to Assess Chelation Therapy (TACT)
Status: Enrolling
Updated: 8/30/2013
Click here to add this to my saved trials
Trial to Assess Chelation Therapy (TACT)
Updated: 8/30/2013
Trial to Assess Chelation Therapy (TACT)
Status: Enrolling
Updated: 8/30/2013
Trial to Assess Chelation Therapy (TACT)
Updated: 8/30/2013
Trial to Assess Chelation Therapy (TACT)
Status: Enrolling
Updated: 8/30/2013
Click here to add this to my saved trials
Trial to Assess Chelation Therapy (TACT)
Updated: 8/30/2013
Trial to Assess Chelation Therapy (TACT)
Status: Enrolling
Updated: 8/30/2013
Trial to Assess Chelation Therapy (TACT)
Updated: 8/30/2013
Trial to Assess Chelation Therapy (TACT)
Status: Enrolling
Updated: 8/30/2013
Click here to add this to my saved trials
Trial to Assess Chelation Therapy (TACT)
Updated: 8/30/2013
Trial to Assess Chelation Therapy (TACT)
Status: Enrolling
Updated: 8/30/2013
Trial to Assess Chelation Therapy (TACT)
Updated: 8/30/2013
Trial to Assess Chelation Therapy (TACT)
Status: Enrolling
Updated: 8/30/2013
Click here to add this to my saved trials
Trial to Assess Chelation Therapy (TACT)
Updated: 8/30/2013
Trial to Assess Chelation Therapy (TACT)
Status: Enrolling
Updated: 8/30/2013
Trial to Assess Chelation Therapy (TACT)
Updated: 8/30/2013
Trial to Assess Chelation Therapy (TACT)
Status: Enrolling
Updated: 8/30/2013
Click here to add this to my saved trials
Trial to Assess Chelation Therapy (TACT)
Updated: 8/30/2013
Trial to Assess Chelation Therapy (TACT)
Status: Enrolling
Updated: 8/30/2013
Trial to Assess Chelation Therapy (TACT)
Updated: 8/30/2013
Trial to Assess Chelation Therapy (TACT)
Status: Enrolling
Updated: 8/30/2013
Click here to add this to my saved trials
Trial to Assess Chelation Therapy (TACT)
Updated: 8/30/2013
Trial to Assess Chelation Therapy (TACT)
Status: Enrolling
Updated: 8/30/2013
Trial to Assess Chelation Therapy (TACT)
Updated: 8/30/2013
Trial to Assess Chelation Therapy (TACT)
Status: Enrolling
Updated: 8/30/2013
Click here to add this to my saved trials
Trial to Assess Chelation Therapy (TACT)
Updated: 8/30/2013
Trial to Assess Chelation Therapy (TACT)
Status: Enrolling
Updated: 8/30/2013
Trial to Assess Chelation Therapy (TACT)
Updated: 8/30/2013
Trial to Assess Chelation Therapy (TACT)
Status: Enrolling
Updated: 8/30/2013
Click here to add this to my saved trials
Trial to Assess Chelation Therapy (TACT)
Updated: 8/30/2013
Trial to Assess Chelation Therapy (TACT)
Status: Enrolling
Updated: 8/30/2013
Trial to Assess Chelation Therapy (TACT)
Updated: 8/30/2013
Trial to Assess Chelation Therapy (TACT)
Status: Enrolling
Updated: 8/30/2013
Click here to add this to my saved trials
Trial to Assess Chelation Therapy (TACT)
Updated: 8/30/2013
Trial to Assess Chelation Therapy (TACT)
Status: Enrolling
Updated: 8/30/2013
Trial to Assess Chelation Therapy (TACT)
Updated: 8/30/2013
Trial to Assess Chelation Therapy (TACT)
Status: Enrolling
Updated: 8/30/2013
Click here to add this to my saved trials
Trial to Assess Chelation Therapy (TACT)
Updated: 8/30/2013
Trial to Assess Chelation Therapy (TACT)
Status: Enrolling
Updated: 8/30/2013
Trial to Assess Chelation Therapy (TACT)
Updated: 8/30/2013
Trial to Assess Chelation Therapy (TACT)
Status: Enrolling
Updated: 8/30/2013
Click here to add this to my saved trials
Trial to Assess Chelation Therapy (TACT)
Updated: 8/30/2013
Trial to Assess Chelation Therapy (TACT)
Status: Enrolling
Updated: 8/30/2013
Trial to Assess Chelation Therapy (TACT)
Updated: 8/30/2013
Trial to Assess Chelation Therapy (TACT)
Status: Enrolling
Updated: 8/30/2013
Click here to add this to my saved trials
Trial to Assess Chelation Therapy (TACT)
Updated: 8/30/2013
Trial to Assess Chelation Therapy (TACT)
Status: Enrolling
Updated: 8/30/2013
Trial to Assess Chelation Therapy (TACT)
Updated: 8/30/2013
Trial to Assess Chelation Therapy (TACT)
Status: Enrolling
Updated: 8/30/2013
Click here to add this to my saved trials
Trial to Assess Chelation Therapy (TACT)
Updated: 8/30/2013
Trial to Assess Chelation Therapy (TACT)
Status: Enrolling
Updated: 8/30/2013
Trial to Assess Chelation Therapy (TACT)
Updated: 8/30/2013
Trial to Assess Chelation Therapy (TACT)
Status: Enrolling
Updated: 8/30/2013
Click here to add this to my saved trials
Trial to Assess Chelation Therapy (TACT)
Updated: 8/30/2013
Trial to Assess Chelation Therapy (TACT)
Status: Enrolling
Updated: 8/30/2013
Trial to Assess Chelation Therapy (TACT)
Updated: 8/30/2013
Trial to Assess Chelation Therapy (TACT)
Status: Enrolling
Updated: 8/30/2013
Click here to add this to my saved trials
Trial to Assess Chelation Therapy (TACT)
Updated: 8/30/2013
Trial to Assess Chelation Therapy (TACT)
Status: Enrolling
Updated: 8/30/2013
Trial to Assess Chelation Therapy (TACT)
Updated: 8/30/2013
Trial to Assess Chelation Therapy (TACT)
Status: Enrolling
Updated: 8/30/2013
Click here to add this to my saved trials
Trial to Assess Chelation Therapy (TACT)
Updated: 8/30/2013
Trial to Assess Chelation Therapy (TACT)
Status: Enrolling
Updated: 8/30/2013
Trial to Assess Chelation Therapy (TACT)
Updated: 8/30/2013
Trial to Assess Chelation Therapy (TACT)
Status: Enrolling
Updated: 8/30/2013
Click here to add this to my saved trials
Trial to Assess Chelation Therapy (TACT)
Updated: 8/30/2013
Trial to Assess Chelation Therapy (TACT)
Status: Enrolling
Updated: 8/30/2013
Trial to Assess Chelation Therapy (TACT)
Updated: 8/30/2013
Trial to Assess Chelation Therapy (TACT)
Status: Enrolling
Updated: 8/30/2013
Click here to add this to my saved trials
Trial to Assess Chelation Therapy (TACT)
Updated: 8/30/2013
Trial to Assess Chelation Therapy (TACT)
Status: Enrolling
Updated: 8/30/2013
Trial to Assess Chelation Therapy (TACT)
Updated: 8/30/2013
Trial to Assess Chelation Therapy (TACT)
Status: Enrolling
Updated: 8/30/2013
Click here to add this to my saved trials
Trial to Assess Chelation Therapy (TACT)
Updated: 8/30/2013
Trial to Assess Chelation Therapy (TACT)
Status: Enrolling
Updated: 8/30/2013
Trial to Assess Chelation Therapy (TACT)
Updated: 8/30/2013
Trial to Assess Chelation Therapy (TACT)
Status: Enrolling
Updated: 8/30/2013
Click here to add this to my saved trials
Trial to Assess Chelation Therapy (TACT)
Updated: 8/30/2013
Trial to Assess Chelation Therapy (TACT)
Status: Enrolling
Updated: 8/30/2013
Trial to Assess Chelation Therapy (TACT)
Updated: 8/30/2013
Trial to Assess Chelation Therapy (TACT)
Status: Enrolling
Updated: 8/30/2013
Click here to add this to my saved trials
Trial to Assess Chelation Therapy (TACT)
Updated: 8/30/2013
Trial to Assess Chelation Therapy (TACT)
Status: Enrolling
Updated: 8/30/2013
Trial to Assess Chelation Therapy (TACT)
Updated: 8/30/2013
Trial to Assess Chelation Therapy (TACT)
Status: Enrolling
Updated: 8/30/2013
Click here to add this to my saved trials
African-American Pharmacogenetics
Updated: 9/3/2013
African-American Pharmacogenetics
Status: Enrolling
Updated: 9/3/2013
African-American Pharmacogenetics
Updated: 9/3/2013
African-American Pharmacogenetics
Status: Enrolling
Updated: 9/3/2013
Click here to add this to my saved trials
Dual-Source Computed Tomography to Improve Prediction of Response to Cardiac Resynchronization Therapy
Updated: 9/4/2013
Dual-Source Computed Tomography to Improve Prediction of Response to Cardiac Resynchronization Therapy
Status: Enrolling
Updated: 9/4/2013
Dual-Source Computed Tomography to Improve Prediction of Response to Cardiac Resynchronization Therapy
Updated: 9/4/2013
Dual-Source Computed Tomography to Improve Prediction of Response to Cardiac Resynchronization Therapy
Status: Enrolling
Updated: 9/4/2013
Click here to add this to my saved trials
Safety and Efficacy of Doxycycline in Patients With Non-Ischemic Cardiomyopathy
Updated: 9/4/2013
Phase II Study of Safety and Efficacy of Doxycycline in Patients With Non-Ischemic Cardiomyopathy
Status: Enrolling
Updated: 9/4/2013
Safety and Efficacy of Doxycycline in Patients With Non-Ischemic Cardiomyopathy
Updated: 9/4/2013
Phase II Study of Safety and Efficacy of Doxycycline in Patients With Non-Ischemic Cardiomyopathy
Status: Enrolling
Updated: 9/4/2013
Click here to add this to my saved trials
Open-label, Test-retest Study to Assess the Reproducibility of Quantitative Measurements of Myocardial Uptake of AdreView™
Updated: 9/5/2013
A Phase 4, Open-label Test-retest Study to Assess the Reproducibility of Quantitative Measurements of Myocardial Uptake of AdreView™ (Iobenguane I 123 Injection)
Status: Enrolling
Updated: 9/5/2013
Open-label, Test-retest Study to Assess the Reproducibility of Quantitative Measurements of Myocardial Uptake of AdreView™
Updated: 9/5/2013
A Phase 4, Open-label Test-retest Study to Assess the Reproducibility of Quantitative Measurements of Myocardial Uptake of AdreView™ (Iobenguane I 123 Injection)
Status: Enrolling
Updated: 9/5/2013
Click here to add this to my saved trials
Tissue Removal Assessment With Ultrasound of THe SFA and Popliteal
Updated: 9/9/2013
Tissue Removal Assessment With Ultrasound of THe SFA and Popliteal (TRUTH Study)
Status: Enrolling
Updated: 9/9/2013
Tissue Removal Assessment With Ultrasound of THe SFA and Popliteal
Updated: 9/9/2013
Tissue Removal Assessment With Ultrasound of THe SFA and Popliteal (TRUTH Study)
Status: Enrolling
Updated: 9/9/2013
Click here to add this to my saved trials
Safety and Efficacy Trial to Treat Diastolic Heart Failure Using Ambrisentan
Updated: 9/16/2013
Safety and Efficacy Trial Using Ambrisentan for Pulmonary Hypertension Associated With Congestive Heart Failure With Preserved Left Ventricular Ejection Fraction
Status: Enrolling
Updated: 9/16/2013
Safety and Efficacy Trial to Treat Diastolic Heart Failure Using Ambrisentan
Updated: 9/16/2013
Safety and Efficacy Trial Using Ambrisentan for Pulmonary Hypertension Associated With Congestive Heart Failure With Preserved Left Ventricular Ejection Fraction
Status: Enrolling
Updated: 9/16/2013
Click here to add this to my saved trials
A Study of CK-2017357 in Patients With Peripheral Artery Disease and Symptomatic Claudication
Updated: 9/16/2013
A Phase II, Double-Blind, Randomized, Placebo-Controlled, Three-Way Crossover, Pharmacokinetic and Pharmacodynamic Study of CK-2017357 in Patients With Claudication
Status: Enrolling
Updated: 9/16/2013
A Study of CK-2017357 in Patients With Peripheral Artery Disease and Symptomatic Claudication
Updated: 9/16/2013
A Phase II, Double-Blind, Randomized, Placebo-Controlled, Three-Way Crossover, Pharmacokinetic and Pharmacodynamic Study of CK-2017357 in Patients With Claudication
Status: Enrolling
Updated: 9/16/2013
Click here to add this to my saved trials
A Study of CK-2017357 in Patients With Peripheral Artery Disease and Symptomatic Claudication
Updated: 9/16/2013
A Phase II, Double-Blind, Randomized, Placebo-Controlled, Three-Way Crossover, Pharmacokinetic and Pharmacodynamic Study of CK-2017357 in Patients With Claudication
Status: Enrolling
Updated: 9/16/2013
A Study of CK-2017357 in Patients With Peripheral Artery Disease and Symptomatic Claudication
Updated: 9/16/2013
A Phase II, Double-Blind, Randomized, Placebo-Controlled, Three-Way Crossover, Pharmacokinetic and Pharmacodynamic Study of CK-2017357 in Patients With Claudication
Status: Enrolling
Updated: 9/16/2013
Click here to add this to my saved trials
A Study of CK-2017357 in Patients With Peripheral Artery Disease and Symptomatic Claudication
Updated: 9/16/2013
A Phase II, Double-Blind, Randomized, Placebo-Controlled, Three-Way Crossover, Pharmacokinetic and Pharmacodynamic Study of CK-2017357 in Patients With Claudication
Status: Enrolling
Updated: 9/16/2013
A Study of CK-2017357 in Patients With Peripheral Artery Disease and Symptomatic Claudication
Updated: 9/16/2013
A Phase II, Double-Blind, Randomized, Placebo-Controlled, Three-Way Crossover, Pharmacokinetic and Pharmacodynamic Study of CK-2017357 in Patients With Claudication
Status: Enrolling
Updated: 9/16/2013
Click here to add this to my saved trials
A Study of CK-2017357 in Patients With Peripheral Artery Disease and Symptomatic Claudication
Updated: 9/16/2013
A Phase II, Double-Blind, Randomized, Placebo-Controlled, Three-Way Crossover, Pharmacokinetic and Pharmacodynamic Study of CK-2017357 in Patients With Claudication
Status: Enrolling
Updated: 9/16/2013
A Study of CK-2017357 in Patients With Peripheral Artery Disease and Symptomatic Claudication
Updated: 9/16/2013
A Phase II, Double-Blind, Randomized, Placebo-Controlled, Three-Way Crossover, Pharmacokinetic and Pharmacodynamic Study of CK-2017357 in Patients With Claudication
Status: Enrolling
Updated: 9/16/2013
Click here to add this to my saved trials
A Study of CK-2017357 in Patients With Peripheral Artery Disease and Symptomatic Claudication
Updated: 9/16/2013
A Phase II, Double-Blind, Randomized, Placebo-Controlled, Three-Way Crossover, Pharmacokinetic and Pharmacodynamic Study of CK-2017357 in Patients With Claudication
Status: Enrolling
Updated: 9/16/2013
A Study of CK-2017357 in Patients With Peripheral Artery Disease and Symptomatic Claudication
Updated: 9/16/2013
A Phase II, Double-Blind, Randomized, Placebo-Controlled, Three-Way Crossover, Pharmacokinetic and Pharmacodynamic Study of CK-2017357 in Patients With Claudication
Status: Enrolling
Updated: 9/16/2013
Click here to add this to my saved trials
A Study of CK-2017357 in Patients With Peripheral Artery Disease and Symptomatic Claudication
Updated: 9/16/2013
A Phase II, Double-Blind, Randomized, Placebo-Controlled, Three-Way Crossover, Pharmacokinetic and Pharmacodynamic Study of CK-2017357 in Patients With Claudication
Status: Enrolling
Updated: 9/16/2013
A Study of CK-2017357 in Patients With Peripheral Artery Disease and Symptomatic Claudication
Updated: 9/16/2013
A Phase II, Double-Blind, Randomized, Placebo-Controlled, Three-Way Crossover, Pharmacokinetic and Pharmacodynamic Study of CK-2017357 in Patients With Claudication
Status: Enrolling
Updated: 9/16/2013
Click here to add this to my saved trials
A Study of CK-2017357 in Patients With Peripheral Artery Disease and Symptomatic Claudication
Updated: 9/16/2013
A Phase II, Double-Blind, Randomized, Placebo-Controlled, Three-Way Crossover, Pharmacokinetic and Pharmacodynamic Study of CK-2017357 in Patients With Claudication
Status: Enrolling
Updated: 9/16/2013
A Study of CK-2017357 in Patients With Peripheral Artery Disease and Symptomatic Claudication
Updated: 9/16/2013
A Phase II, Double-Blind, Randomized, Placebo-Controlled, Three-Way Crossover, Pharmacokinetic and Pharmacodynamic Study of CK-2017357 in Patients With Claudication
Status: Enrolling
Updated: 9/16/2013
Click here to add this to my saved trials
A Study of CK-2017357 in Patients With Peripheral Artery Disease and Symptomatic Claudication
Updated: 9/16/2013
A Phase II, Double-Blind, Randomized, Placebo-Controlled, Three-Way Crossover, Pharmacokinetic and Pharmacodynamic Study of CK-2017357 in Patients With Claudication
Status: Enrolling
Updated: 9/16/2013
A Study of CK-2017357 in Patients With Peripheral Artery Disease and Symptomatic Claudication
Updated: 9/16/2013
A Phase II, Double-Blind, Randomized, Placebo-Controlled, Three-Way Crossover, Pharmacokinetic and Pharmacodynamic Study of CK-2017357 in Patients With Claudication
Status: Enrolling
Updated: 9/16/2013
Click here to add this to my saved trials
A Study of CK-2017357 in Patients With Peripheral Artery Disease and Symptomatic Claudication
Updated: 9/16/2013
A Phase II, Double-Blind, Randomized, Placebo-Controlled, Three-Way Crossover, Pharmacokinetic and Pharmacodynamic Study of CK-2017357 in Patients With Claudication
Status: Enrolling
Updated: 9/16/2013
A Study of CK-2017357 in Patients With Peripheral Artery Disease and Symptomatic Claudication
Updated: 9/16/2013
A Phase II, Double-Blind, Randomized, Placebo-Controlled, Three-Way Crossover, Pharmacokinetic and Pharmacodynamic Study of CK-2017357 in Patients With Claudication
Status: Enrolling
Updated: 9/16/2013
Click here to add this to my saved trials
A Study of CK-2017357 in Patients With Peripheral Artery Disease and Symptomatic Claudication
Updated: 9/16/2013
A Phase II, Double-Blind, Randomized, Placebo-Controlled, Three-Way Crossover, Pharmacokinetic and Pharmacodynamic Study of CK-2017357 in Patients With Claudication
Status: Enrolling
Updated: 9/16/2013
A Study of CK-2017357 in Patients With Peripheral Artery Disease and Symptomatic Claudication
Updated: 9/16/2013
A Phase II, Double-Blind, Randomized, Placebo-Controlled, Three-Way Crossover, Pharmacokinetic and Pharmacodynamic Study of CK-2017357 in Patients With Claudication
Status: Enrolling
Updated: 9/16/2013
Click here to add this to my saved trials
A Study of CK-2017357 in Patients With Peripheral Artery Disease and Symptomatic Claudication
Updated: 9/16/2013
A Phase II, Double-Blind, Randomized, Placebo-Controlled, Three-Way Crossover, Pharmacokinetic and Pharmacodynamic Study of CK-2017357 in Patients With Claudication
Status: Enrolling
Updated: 9/16/2013
A Study of CK-2017357 in Patients With Peripheral Artery Disease and Symptomatic Claudication
Updated: 9/16/2013
A Phase II, Double-Blind, Randomized, Placebo-Controlled, Three-Way Crossover, Pharmacokinetic and Pharmacodynamic Study of CK-2017357 in Patients With Claudication
Status: Enrolling
Updated: 9/16/2013
Click here to add this to my saved trials
A Study of CK-2017357 in Patients With Peripheral Artery Disease and Symptomatic Claudication
Updated: 9/16/2013
A Phase II, Double-Blind, Randomized, Placebo-Controlled, Three-Way Crossover, Pharmacokinetic and Pharmacodynamic Study of CK-2017357 in Patients With Claudication
Status: Enrolling
Updated: 9/16/2013
A Study of CK-2017357 in Patients With Peripheral Artery Disease and Symptomatic Claudication
Updated: 9/16/2013
A Phase II, Double-Blind, Randomized, Placebo-Controlled, Three-Way Crossover, Pharmacokinetic and Pharmacodynamic Study of CK-2017357 in Patients With Claudication
Status: Enrolling
Updated: 9/16/2013
Click here to add this to my saved trials
A Study of CK-2017357 in Patients With Peripheral Artery Disease and Symptomatic Claudication
Updated: 9/16/2013
A Phase II, Double-Blind, Randomized, Placebo-Controlled, Three-Way Crossover, Pharmacokinetic and Pharmacodynamic Study of CK-2017357 in Patients With Claudication
Status: Enrolling
Updated: 9/16/2013
A Study of CK-2017357 in Patients With Peripheral Artery Disease and Symptomatic Claudication
Updated: 9/16/2013
A Phase II, Double-Blind, Randomized, Placebo-Controlled, Three-Way Crossover, Pharmacokinetic and Pharmacodynamic Study of CK-2017357 in Patients With Claudication
Status: Enrolling
Updated: 9/16/2013
Click here to add this to my saved trials
A Study of CK-2017357 in Patients With Peripheral Artery Disease and Symptomatic Claudication
Updated: 9/16/2013
A Phase II, Double-Blind, Randomized, Placebo-Controlled, Three-Way Crossover, Pharmacokinetic and Pharmacodynamic Study of CK-2017357 in Patients With Claudication
Status: Enrolling
Updated: 9/16/2013
A Study of CK-2017357 in Patients With Peripheral Artery Disease and Symptomatic Claudication
Updated: 9/16/2013
A Phase II, Double-Blind, Randomized, Placebo-Controlled, Three-Way Crossover, Pharmacokinetic and Pharmacodynamic Study of CK-2017357 in Patients With Claudication
Status: Enrolling
Updated: 9/16/2013
Click here to add this to my saved trials
The GORE Viabahn Endoprosthesis for the Treatment of Venous Occlusions and Stenoses
Updated: 9/17/2013
Evaluation of GORE VIABAHN Endoprosthesis With Heparin Bioactive Surface for the Treatment of Venous Occlusions and Stenoses
Status: Enrolling
Updated: 9/17/2013
The GORE Viabahn Endoprosthesis for the Treatment of Venous Occlusions and Stenoses
Updated: 9/17/2013
Evaluation of GORE VIABAHN Endoprosthesis With Heparin Bioactive Surface for the Treatment of Venous Occlusions and Stenoses
Status: Enrolling
Updated: 9/17/2013
Click here to add this to my saved trials
Corticosteroid Therapy in Refractory Shock Following Cardiac Arrest
Updated: 9/23/2013
Corticosteroids Therapy in Refractory Shock Following Cardiac Arrest
Status: Enrolling
Updated: 9/23/2013
Corticosteroid Therapy in Refractory Shock Following Cardiac Arrest
Updated: 9/23/2013
Corticosteroids Therapy in Refractory Shock Following Cardiac Arrest
Status: Enrolling
Updated: 9/23/2013
Click here to add this to my saved trials
Nutritional Failure in Infants With Single Ventricle Congenital Heart Disease
Updated: 10/4/2013
Nutritional Failure in Infants With Single Ventricle Congenital Heart Disease
Status: Enrolling
Updated: 10/4/2013
Nutritional Failure in Infants With Single Ventricle Congenital Heart Disease
Updated: 10/4/2013
Nutritional Failure in Infants With Single Ventricle Congenital Heart Disease
Status: Enrolling
Updated: 10/4/2013
Click here to add this to my saved trials
High Ticagrelor Loading Dose in STEMI
Updated: 10/17/2013
Pharmacodynamic Profiles of Ticagrelor in Patients With ST Elevation Myocardial Infarction: A Randomized Comparison of Different Loading Dosage Regimens
Status: Enrolling
Updated: 10/17/2013
High Ticagrelor Loading Dose in STEMI
Updated: 10/17/2013
Pharmacodynamic Profiles of Ticagrelor in Patients With ST Elevation Myocardial Infarction: A Randomized Comparison of Different Loading Dosage Regimens
Status: Enrolling
Updated: 10/17/2013
Click here to add this to my saved trials